Drug Trial Radar · NCT07446439
A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use
Last checked: Nov 19, 2026Latest source record: Apr 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
280
Planned (sponsor's estimate)
Start
Mar 27, 2026
Primary completion
Dec 1, 2026
Study completion Dec 1, 2026
Sponsor
- Lead sponsor
- Vanda PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Mar 3, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The goal of this study is to measure the effects of using Tradipitant to treat nausea and vomiting induced by GLP-1R agonist use in adults with class I or class II obesity, or adults who are overweight with at least one weight-related condition. The study is placebo-controlled with two treatment arms.
Conditions
- Nausea and Vomiting
- Obesity
Interventions
TradipitantDrug
Oral Capsule
PlaceboDrug
Oral Capsule
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of participants with at least 1 vomiting episode per week in the tradipitant group compared to the placebo group as measured by a daily symptom diary.Time frame: 1 week
Locations
10 sites in 1 country. Site status is shown where the registry gives one.
Vanda Investigational Site
Los Angeles, California · Recruiting
Vanda Investigational Site
San Diego, California · Recruiting
Vanda Investigational Site
San Jose, California · Not yet recruiting
Vanda Investigational Site
Tampa, Florida · Recruiting
Vanda Investigational Site
Hamilton, New Jersey · Not yet recruiting
Vanda Investigational Site
New York, New York · Not yet recruiting
Vanda Investigational Site
Syosset, New York · Not yet recruiting
Vanda Investigational Site
Plano, Texas · Not yet recruiting
Vanda Investigational Site
San Antonio, Texas · Not yet recruiting
Vanda Investigational Site
Burke, Virginia · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.